IMPACT OF INOTERSEN ON GENERIC HEALTH-RELATED QUALITY OF LIFE FOR PATIENTS WITH HATTR AMYLOIDOSIS: RESULTS FROM A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL

被引：0
|
作者：
Yarlas, A. [1 ]
Kessler, Sikora A. [1 ]
Lovley, A. [1 ]
Guthrie, S. [2 ]
Pollock, M. [2 ]
White, M. K. [1 ]
机构：
[1] Optum, Johnston, RI USA
[2] Akcea Therapeut, Cambridge, MA USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND152
引用
收藏
页码：S354 / S354
页数：1
相关论文
共 50 条
  • [1] IMPACT OF INOTERSEN ON CONDITION-SPECIFIC QUALITY OF LIFE (QOL) FOR PATIENTS WITH HATTR AMYLOIDOSIS: RESULTS FROM A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
    Kessler, Sikora A.
    Yarlas, A.
    Lovley, A.
    Guthrie, S.
    Pollock, M.
    White, M. K.
    [J]. VALUE IN HEALTH, 2018, 21 : S354 - S354
  • [2] The impact of disease and treatment on generic health-related quality of life in patients with hATTR amyloidosis: SF-36v2 results from a double-blind placebocontrolled trial of inotersen
    Yarlas, A.
    Kessler, A. Sikora
    Lovley, A.
    Guthrie, S. D.
    Pollock, M.
    Coelho, T.
    Conceicao, I.
    Obici, L.
    White, M. K.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 717 - 717
  • [3] Impact of Inotersen on Subgroups of Patients with Hereditary TTR Amyloidosis: Results from a Double-Blind Placebo-Controlled Trial
    Yarlas, Aaron
    Merlini, Giampaolo
    White, Michelle K.
    Kessler, Asia Sikora
    Lovley, Andrew
    Guthrie, Spencer D.
    Pollock, Michael
    Gertz, Morie A.
    [J]. BLOOD, 2018, 132
  • [4] Impact of Inotersen on Functioning and Activities of Daily Living for Patients with Hereditary TTR Amyloidosis: Results from a Double-Blind Placebo-Controlled Trial
    Yarlas, Aaron
    Merlini, Giampaolo
    White, Michelle K.
    Kessler, Asia Sikora
    Lovley, Andrew
    Guthrie, Spencer D.
    Pollock, Michael
    Gertz, Morie A.
    [J]. BLOOD, 2018, 132
  • [5] Health-related quality of life (HRQOL) and disability in chronic migraine: Results from a randomized, double-blind, placebo-controlled trial of topiramate
    Dodick, David
    Silberstein, Stephen
    Saper, Joel
    Mathew, Ninan
    Hulihan, Joseph
    Crivera, Concetta
    Rupnow, Marcia
    Mao, Lion
    Greenberg, Steven
    [J]. NEUROLOGY, 2007, 68 (12) : A370 - A370
  • [6] Curcumin ameliorates health-related quality of life in patients with liver cirrhosis: A randomized, double-blind placebo-controlled trial
    Nouri-Vaskeh, Masoud
    Afshan, Hossein
    Mahdavi, Aida Malek
    Alizadeh, Leila
    Fan, Xiude
    Zarei, Mohammad
    [J]. COMPLEMENTARY THERAPIES IN MEDICINE, 2020, 49
  • [7] ANALYSIS OF RESPONSES TO SF-36V2 ITEMS FOR PATIENTS WITH HATTR AMYLOIDOSIS: RESULTS FROM A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
    Yarlas, A.
    Kessler, Sikora A.
    Lovley, A.
    Guthrie, S.
    Pollock, M.
    White, M. K.
    [J]. VALUE IN HEALTH, 2018, 21 : S354 - S354
  • [8] Factors affecting the health-related quality of life of patients with cervical dystonia and impact of treatment with abobotulinumtoxinA (Dysport): results from a randomised, double-blind, placebo-controlled study
    Mordin, Margaret
    Masaquel, Catherine
    Abbott, Chandra
    Copley-Merriman, Catherine
    [J]. BMJ OPEN, 2014, 4 (10):
  • [9] Impact of ustekinumab on health-related quality of life in Japanese patients with moderate-to-severe plaque psoriasis: Results from a randomized, double-blind, placebo-controlled phase 2/3 trial
    Nakagawa, Hidemi
    Schenkel, Brad
    Kato, Mai
    Kato, Takeshi
    Igarashi, Atsuyuki
    [J]. JOURNAL OF DERMATOLOGY, 2012, 39 (09): : 761 - 769
  • [10] Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study
    Sanyal, A.
    Younossi, Z. M.
    Bass, N. M.
    Mullen, K. D.
    Poordad, F.
    Brown, R. S.
    Vemuru, R. P.
    Jamal, M. Mazen
    Huang, S.
    Merchant, K.
    Bortey, E.
    Forbes, W. P.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (08) : 853 - 861
12345